Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a 11.677% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
(a) CCCn1c2ccccc2c2cnn(CC(=O)NC3CCCCC3C)c(=O)c21
(b) Nc1ncc(-c2ncc(C(F)(F)F)cc2Cl)cn1
(c) O=C1C2C3C=CC(CNS(=O)(=O)c4ccccc4)(O3)C2C(=O)N1c1ccc(Cl)cc1
Answer: a. CCCn1c2ccccc2c2cnn(CC(=O)NC3CCCCC3C)c(=O)c21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCn1c2ccccc2c2cnn(CC(=O)NC3CCCCC3C)c(=O)c21
CCCn1c2ccccc2c2cnn(CC(=O)NC3CCCCC3C)c(=O)c21
N-(2-methylcyclohexyl)-2-(4-oxo-5-propylpyridazino[4,5-b]indol-3-yl)acetamide